Page 4 - Dcph News Today

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totalling 3,750,000 shares, a growth of 10.9% from the April 30th total of 3,380,000 shares. Approximately 7.0% of the company’s stock are short sold. Based on an average […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) shares traded down 3.1% during mid-day trading on Monday . The stock traded as low as $14.32 and last traded at $14.32. 221,863 shares changed hands during trading, a decline of 71% from the average session volume of 764,351 shares. The stock had previously closed at $14.78. Analyst […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) rose 7.8% during mid-day trading on Monday following insider buying activity. The stock traded as high as $14.85 and last traded at $14.84. Approximately 51,290 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 770,578 shares. The stock had previously closed […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) Director Dennis Leo Walsh purchased 11,000 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Wednesday, May 10th. The stock was bought at an average cost of $13.86 per share, with a total value of $152,460.00. Following the completion of the transaction, the director now owns […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities research analysts at SVB Leerink cut their Q2 2023 EPS estimates for shares of Deciphera Pharmaceuticals in a research note issued to investors on Wednesday, May 3rd. SVB Leerink analyst A. Berens now forecasts that the company will earn ($0.65) per share for the quarter, down […]

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Rating) had its price objective decreased by Stifel Nicolaus from $17.00 to $14.00 in a research note issued to investors on Thursday, The Fly reports. Several other analysts have also issued reports on DCPH. HC Wainwright restated a buy rating and issued a $25.00 price target on shares of Deciphera […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Research analysts at SVB Leerink decreased their FY2025 earnings estimates for shares of Deciphera Pharmaceuticals in a research note issued on Tuesday, April 25th. SVB Leerink analyst A. Berens now forecasts that the company will post earnings per share of $0.26 for the year, down from their […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 3,370,000 shares, a decrease of 40.9% from the March 31st total of 5,700,000 shares. Based on an average daily volume of 745,900 shares, the short-interest ratio is […]

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have given a buy recommendation […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 5,700,000 shares, an increase of 6.9% from the March 15th total of 5,330,000 shares. Currently, 11.0% of the company’s stock are sold short. Based on an average trading volume of […]